• Privacy GDPR

    Privacy Policy

    The European General Data Protection Regulation (GDPR) comes into force on May 25th 2018 and has major implications worldwide. European citizens now have multiple digital rights over their personal details, including the right to be asked to provide consent for the storage of personal details in a database, the right to be asked to provide consent to be contacted, the right to see the personal information stored, the right to be forgotten including having all personal details permanently removed from a database, the right to know who this information is shared with (consent is also required for this), and the right to be contacted should a significant data breach occur. All of these changes must be prospectively acknowledged by the user and cannot be presumed to have occurred. The proof rests with the websites to be able to demonstrate consent has been obtained. It is likely almost all websites in the world will move to this model, unless they wish to limit access to European citizens, which would be difficult technically. Fines for non-compliance with this can reach €20 million. As a result, we have updated our privacy policy accordingly. We took as example the updated privacy policy of Critical Care Reviews, a sister website providing FOAM content...

  • 7th IFAD 2018

    FIRST BATCH OF EARLY BIRD ONLINE REGISTRATIONS SOON OPEN

    November 23rd 2018
    Congress Centre "Pakhuis De Zwijger", Amsterdam, The Netherlands

    We are very pleased to announce the 7th International Fluid Academy Day, which will take place on November 23rd 2018 at Pakhuis De Zwijger in Amsterdam, The Netherlands. The aim of this seventh edition is again to review recent advances in fluid management, and hemodynamic and organ function monitoring in the critical care setting in a comprehensive manner for intensivists, anaesthesiologists and emergency physicians as well as interested internists and surgeons. However the meeting will deal with any broad topic related to critical care. As always it is also a great way to promote professional interaction between faculty members, participants and delegates of the industry. This website is regularly updated. Last modification by Adminstrator (Manu Malbrain) on February 7th at 10:00 AM.

  • About iFAD

    The iFAD started as local initiative form the pharmaceutical working group on fluids from the Ziekenhuis Netwerk Antwerpen (www.zna.be). Today iFAD is integrated within the not-for-profit charitable organization iMERiT, International Medical Education and Research Initiative, under Belgian law and as such the iFAD Organising Committee strongly recognizes and values a constructive partnership with the industry.

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
    verify here.

     

     

     

    Read more

  • Brand new website!

    The IFAD website content is based on the philosophy of FOAM (Free Open Access Medical education – #FOAMed). The organising committee gives their time freely and receives no financial benefit. This in part explains the wonderful passions for philanthropy, sharing, education and innovation that make the IFAD unique.

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
    verify here.

  • Free Open Access Medical Education and Member Benefits

    The International Fluid Academy adheres to the FOAM principles for all website visitors: FREE Open Access Medical Education (#FOAMed #FOAMcc #FOAMus).

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
    verify here.

     

     

    We are very pleased to announce the 7th International Fluid Academy Day, which will take place on November 23rd 2018 at Pakhuis De Zwijger in Amsterdam, The Netherlands. The aim of this seventh edition is again to review recent advances in fluid management, and hemodynamic and organ function monitoring in the critical care setting in a comprehensive manner for intensivists, anaesthesiologists and emergency physicians as well as interested internists and surgeons. However the meeting will deal with any broad topic related to critical care. As always it is also a great way to promote professional interaction between faculty members, participants and delegates of the industry.

    Read more

The four questions of fluid therapy (Part 1.3.)

The four questions of fluid therapy (Part 1.3.)

Part 1.3. of series on fluid therapy

Why should I bother about the ebb and flow phase of shock? An illustrative case report

Multiple choice question 2

At this stage, the participants of the ISICEM and IFAD meetings were asked the second multiple choice question (MCQ2): “Taking into account the results obtained with the transpulmonary thermodilution, what is your treatment of choice at this stage?” Possible answers were: 1) norepinephrine; 2) dobutamine; 3) fluid bolus; 4) diuretics or 5) other. Figure 5 shows the results of three votings.

Fig5
Figure 5. Multiple choice question 2 (MCQ2): “Taking into account the results obtained with the transpulmonary thermodilution, what is your treatment of choice at this stage?” Distribution of answers (in percentage) on MCQ2, blue squares denote the voting results of the ISICEM 2012 meeting, red squares show the results of the iFAD 2012 meeting, and green squares denote the voting results of the ISICEM 2013 meeting.

Again, physicians were reluctant to fill the patient initially (with only 0 to 22% indicating to give a fluid bolus). This patient had a relatively normal preload according to the volumetric preload indicator as was obtained by PiCCO (GEDVI 757 ml/m2) but a high preload according to the barometric preload indicator (CVP 16 mmHg). Measurement of bladder pressure showed a slightly increased IAP of 12 mmHg [17]. The Surviving Sepsis Campaign Guidelines (SSCG) originally recommended that patients should be resuscitated towards a CVP range of 8-12 mmHg [18]. The previous revision of the SSCG still advocates initial fluid management based on CVP measurements [19]. However, using pressures to measure preload has been found to be inaccurate time and time again, particularly in patients ventilated with intermittent positive pressure ventilation (IPPV), (auto) PEEP, post cardiac surgery, obesity and those with intra-abdominal hypertension or abdominal compartment syndrome [5, 20]. Using a CVP threshold therefore may lead to over- but also under-resuscitation. Although it is re-assuring and noteworthy that the previous SSCG version does mention the effects of increased ITP and IAP on CVP:

“In mechanically ventilated patients or those with known preexisting decreased ventricular compliance, a higher target CVP of 12 to 15 mm Hg should be achieved to account for the impediment in filling. Similar consideration may be warranted in circumstances of increased abdominal pressure. Elevated CVP may also be seen with preexisting clinically significant pulmonary artery hypertension, making use of this variable untenable for judging intravascular volume status.”

Within this respect the compliance of the thorax and the abdomen are key elements in order to explain the index of transmission of a given pressure from one compartment to another [19]:

“The use of lung-protective strategies for patients with ARDS… has been widely accepted, but the precise choice of tidal volume… may require adjustment for such factors as the plateau pressure achieved, the level of positive end-expiratory pressure chosen, the compliance of the thoracoabdominal compartment, …” 

This lead recently to the recognition of the polycompartment syndrome [21, 22]. The last version of the SSCG finally has left the CVP criterion and has introduced functional hemodynamics and passive leg raising test (PLR)[23, 24].

Further course

In this case study (dating before the publication of the big fluid trials) the patient was given small volume resuscitation with hyperhaes (Fresenius Kabi) at a dose of 4ml/kg given as a bolus over 10-15 minutes combined with 1000 ml of balanced colloids (Volulyte, 6% hydroxyethyl starch 130/0.4), following the results obtained with the transpulmonary thermodilution.

Editorial Comment: “We have to note that after the EMEA PRAC recommendations, nowadays the use of starches cannot be advocated in patients with sepsis, burns or kidney injury. Instead of hyperhaes, a hypertonic salt solution 6% can be used.”

The patient remained on a dobutamine infusion (9 ug/kg/min) and norepinephrine (0.4 ug/kg/min). The following day (day 2) his CI increased to 5.7 L/min.m2, GEDVI increased to 900  ml/m2 and EVLWI had decreased to 14 ml/kg PBW (Table 2). Despite the filling, his CVP decreased from 16 to 6 mmHg, illustrating the opposite changes between barometric and volumetric preload indices due to increased intrathoracic pressure.

This is an example of a therapeutic dilemma or conflict [25]. A therapeutic conflict is a situation where each of the possible therapeutic decisions carries some potential harm [26]. In high-risk patients, the decision about fluid administration should be done within the context of a therapeutic conflict. Therapeutic conflicts are the biggest challenge for protocolized cardiovascular management in anesthetized and critically ill patients. A therapeutic conflict is where our decisions can make the most difference. Although the patient had evidence of severe pulmonary edema (EVLWI 38 ml/kg PBW) the decision was made to give fluids because the PPV was high and the PLR test was positive. Also, the GEDVI was relatively low in relation to the GEF, despite the increased CVP and increased left ventricular end diastolic area (from the ultrasound) [6, 27]. Cardiac US further showed that his inferior vena cava collapsibility index (IVCCI) was almost 50% [28](Figure 6).

Fig6 IVCCI
Figure 6. Inferior vena cava collapsibility index (IVCCI) was calculated at 50%

What was really important to know for this patient was the type of curve and where he was on his Frank Starling curve (Figure 7, panel A).

Fig7A starling

Figure 7. Panel A. Relation between preload and stroke volume in different fluid loading conditions

Evidence shows that when the global end-diastolic volume and the right ventricular end-diastolic volume are corrected for the GEF they correlate more closely especially when compared to the change in CVP or PAOP (Figure 7, panel B) [6].  

Fig7B frank

Figure 7. Panel B. Ventricular function curves by global ejection fraction (GEF). The patient’s GEDVI must be interpreted in conjunction with the patient’s GEF (GEF - global ejection fraction, GEDVI - global end-diastolic volume index).

Observation of the transpulmonary thermodilution curve also allowed us to get further diagnostic clues (Figure 8 and Video 3).

Fig8
Figure 8. Screen shot (obtained from a PiCCO2 monitor) from the initial transpulmonary thermodilution curve, showing a premature hump (red arrow) after the bolus injection (indicated by white horizontal line on the bottom left), hence excluding cross-talk phenomenon.

Multiple choice question 3

At this stage, the participants of the ISICEM and IFAD meetings were asked the third multiple choice question (MCQ3): “What is the premature hump that appeared on the transpulmonary thermodilution curve?”. Possible answers were:

1) Nothing to worry about, it is just an example of the crosstalk phenomenon
2) It is related to thermal bolus mixing
3) It may be an indicator of a right-to-left shunt due to pulmonary hypertension
4) It is related to a wrong or false measurement technique
5) I don't know

Continue

Leave a comment

You are commenting as guest.

Become a free member!

    Fluid_Academy

    Facebook

    Welcome to our new Blog!

    Petition to retire the surviving sepsis campaign guidelines

    Petition to retire the surviving sepsis campaign guidelines

    Fill in the petition. Guidelines that go beyond guidance and move to regimented, time-based prescriptions of care must be based on unassailable evidence. Even then, the clinician's assessment of the individual patient should allow a diversion from the guideline directed care.

    Read more

    #IFADmini at the #14ECCC Dubai 2018

    #IFADmini at the #14ECCC Dubai 2018

    Summary slide from the day

    Read more

    What is the ideal IV fluid? (#iFADmini #IFAD2018)

    What is the ideal IV fluid? (#iFADmini #IFAD2018)

    Read further and find out whether or not the ideal intravenous plasma substitution fluid exists or not?

    Read more

    The neglected role of abdominal compliance (#iFADmini #IFAD2018)

    The neglected role of abdominal compliance (#iFADmini #IFAD2018)

    Read on, if you want to know how abdominal compliance plays a role in organ-organ interactions

    Read more

    What is new in IAP measurement (#IFAD2018 #iFADmini)

    What is new in IAP measurement (#IFAD2018 #iFADmini)

    In this #ISICEM18 lecture @manu_malbrain discusses the recent advances in IAP measurement as well as the advantages for continuous monitoring

    Read more

    The use of ultrasound in de-resuscitation

    The use of ultrasound in de-resuscitation

    Point-of-care ultrasound as a multimodal approach for fluid management. Can POCUS save the drowning?

    Picture1

    Read more

    Social Media

      like us on Facebook

      follow us on Twitter

      join Discussion group

      join us on Linkedin

      newsletter sign up

      post on the blog